Rare cause of extravasation from implantable venous access device
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ..
Implantable venous access devices are routinely used, but they are not without complications. A 4-year-old male child with B cell acute lymphoblastic leukaemia was planned for chemotherapy. Chemo port was accessed through the right internal jugular vein. Check X-ray was done, which showed the correct placement of the catheter. Two months after chemo port insertion when the patient underwent chemotherapy, he developed a fever and he was started on intravenous antibiotics. On the next two admissions, the patient had a fever with chamber site oedema for which culture was done, which revealed Pseudomonas and Candida, which responded to antibiotic and antifungal therapies. In the successive admission, the patient had immediate local oedema on injecting chemotherapy. Exploration was done, which revealed chamber base perforation. It is an infrequent complication and has been reported in only three studies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
BMJ case reports - 14(2021), 2 vom: 01. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Manimaran, Ponmani Agasthiya [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antineoplastic Agents |
---|
Anmerkungen: |
Date Completed 22.02.2021 Date Revised 02.02.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/bcr-2020-239103 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320875504 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320875504 | ||
003 | DE-627 | ||
005 | 20231225174611.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bcr-2020-239103 |2 doi | |
028 | 5 | 2 | |a pubmed24n1069.xml |
035 | |a (DE-627)NLM320875504 | ||
035 | |a (NLM)33526533 | ||
035 | |a (PII)e239103 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Manimaran, Ponmani Agasthiya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rare cause of extravasation from implantable venous access device |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.02.2021 | ||
500 | |a Date Revised 02.02.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a Implantable venous access devices are routinely used, but they are not without complications. A 4-year-old male child with B cell acute lymphoblastic leukaemia was planned for chemotherapy. Chemo port was accessed through the right internal jugular vein. Check X-ray was done, which showed the correct placement of the catheter. Two months after chemo port insertion when the patient underwent chemotherapy, he developed a fever and he was started on intravenous antibiotics. On the next two admissions, the patient had a fever with chamber site oedema for which culture was done, which revealed Pseudomonas and Candida, which responded to antibiotic and antifungal therapies. In the successive admission, the patient had immediate local oedema on injecting chemotherapy. Exploration was done, which revealed chamber base perforation. It is an infrequent complication and has been reported in only three studies | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Video-Audio Media | |
650 | 4 | |a chemotherapy | |
650 | 4 | |a paediatric oncology | |
650 | 4 | |a paediatric surgery | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Methotrexate |2 NLM | |
650 | 7 | |a YL5FZ2Y5U1 |2 NLM | |
700 | 1 | |a Agarwal, Prakash |e verfasserin |4 aut | |
700 | 1 | |a Ramasundaram, Madhu |e verfasserin |4 aut | |
700 | 1 | |a Sundaram, Jegadeesh |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ case reports |d 2008 |g 14(2021), 2 vom: 01. Feb. |w (DE-627)NLM209291001 |x 1757-790X |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2021 |g number:2 |g day:01 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bcr-2020-239103 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2021 |e 2 |b 01 |c 02 |